Zimmer, OrthoSensor Ink Co-Marketing Partnership (press release)
Agreement Provides VERASENSE Knee Technology for use with Zimmer Knee Systems
OrthoSensor, a leader in intelligent orthopaedics, and Zimmer Holdings, Inc., a global leader in musculoskeletal health, announced today that they have entered into a co-marketing partnership which will marry Zimmer knee systems with OrthoSensor’s VERASENSE Sensor-Assisted Technology.
“While we currently lead the industry in Patient Reported Outcomes (PROMs) with our NexGen Knee, we know that component placement and soft-tissue balancing are critical to patient satisfaction and implant longevity,” said Jeff McCaulley, Zimmer Reconstructive President. “As such, Zimmer is committed to offering the widest array of intelligent instrumentation to assist surgeons. Our collaboration with OrthoSensor, and the ability to leverage real data in soft tissue balancing with VERASENSE, should allow for even more satisfied patients.”
Research has shown that soft tissue balance may aid in the reduction of pain, wear, and implant loosening – while also improving how the knee replacement feels to the patient.1 The OrthoSensor VERASENSE Knee System provides surgeons with real-time data that enables evidence-based intraoperative decisions regarding component position, limb alignment and soft-tissue releases to achieve soft tissue balance and stability through a full range of motion.
“VERASENSE gives orthopaedic surgeons actionable data during their procedures that helps quantify and verify implant positioning and knee balance,” said Jay Pierce, CEO and President of OrthoSensor. “This agreement allows development of VERASENSE technology that will be used initially with the Zimmer NexGen system, allowing more surgeons to benefit from the data provided to them by VERASENSE. We welcome the Zimmer knee portfolio into the VERASENSE technology platform and look forward to working with Zimmer to improve patient outcomes and satisfaction.”
About OrthoSensor
OrthoSensor, Inc. (www.orthosensor.com) develops and commercializes intelligent orthopaedic devices and data services that provide quantitative feedback to surgeons and hospitals during surgery and post-operatively. The company’s intelligent orthopaedic devices utilize proprietary software, as well as advanced sensor and communications technologies, to enable evidence-based surgical decisions with the goal of improving patient outcomes and reducing the cost of treating musculoskeletal disease.
OrthoSensor and VERASENSE are trademarks of OrthoSensor, Inc.
About Zimmer Holdings, Inc.
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer (www.zimmer.com) designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer’s 2012 sales were approximately $4.5 billion. The Company is supported by the efforts of more than 9,000 employees worldwide.
NexGen and Zimmer are trademarks of Zimmer Holdings, Inc.
1. Babazadeh S, Stoney JD, Lim K, Choong PF. The relevance of ligament balancing in total knee arthroplasty: how important is it? A systematic review of the literature. Orthop Rev (Pavia). 2009 Oct 10;1(2).
FOR MORE INFORMATION:
Brandy Krier
954-604-4540
bkrier@orthosensor.com
SOURCE OrthoSensor, Inc.